High rates of drug resistance in individuals diagnosed with HIV in tenofovir disoproxil fumarate (TDF)-based pre-exposure prophylaxis rollout programs in Kenya, Zimbabwe, Eswatini and South Africa

Authors :: Parikh, U.M.
Kudrick, L.
Levy, L.
Bosek, E.
Chohan, B.
Ndlovu, N.
Mahaka, I.
Hettema, A.
Mullick, S.
McCormick, K.
Wallis, C.
Wiesner, L.
Anderson, P.
Mukui, I.
Masyuko, S.
Mugambi, M.
Mugurungi, O.
Ncube, G.
Dunbar, M.
Dlamini, NA.
Matse, S.
Peterson, J.
Baeten, J.
Celum, C.
Richardson, B.
Castor, D.
Torjesen, K.
Mellors, J.W.
Source :: Journal of the International AIDS Society. July, 2021, Vol. 24 Issue S4, p72, 1 p.
Publication Year :: 2021
Abstract: Background: The ongoing rollout of oral TDF-based PrEP has the potential to reduce HIV incidence in Sub-Saharan Africa (SSA) but HIV drug resistance (HIVDR) in PrEP breakthrough infections could threaten [...]

Subjects :: Drug resistance in microorganisms -- Statistics
Tenofovir -- Patient outcomes
HIV infection -- Statistics -- Drug therapy
Health

Full Text Access

Tools